Karen Miotto

Professor

University of California, Los Angeles

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Karen Miotto is a faculty member at the University of California, Los Angeles (UCLA) in the United States. Her research focuses on alcohol use disorders, including the efficacy of various pharmacological treatments and the psychological aspects of addiction. Recent publications highlight her work on neuroimmune modulators and their effects on treatment responses in individuals with alcohol use disorder. Additionally, she has explored the impact of COVID-19 on the mental health of healthcare professionals within the psychiatry field.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Enrico G. Castillo

Assistant Professor; Associate Vice Chair for Justice, Equity, Diversity, and Inclusion; Health Services and Health Policy Researcher

University of California, Los Angeles

UNITED STATES

View details

Michael Irwin

Distinguished Cousins Professor

University of California, Los Angeles

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Karen Miotto

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial

Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

Before and During the First COVID-19 Surge: Work Conditions, Burnout, and Mental Health Among Resident Physicians in a Department of Psychiatry in the USA.

Alcohol Use Among Treatment-Seeking Individuals With Opioid Use Disorder

Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers

Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial

Ibudilast Moderates the Effect of Mood on Alcohol Craving During Stress Exposure

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Collaborators (2)

Enrico G. Castillo

Michael Irwin

Make your next move.